title: Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema.
authors.affiliation: Division of Allergic Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: motosue.megan@mayo.edu.
authors.forename: Megan S
authors.initials: MS
authors.lastname: Motosue
authors.affiliation: Division of Hematopathology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Howard
authors.affiliation: Division of Hematopathology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Butterfield
mesh_terms: D000368:Aged; D000799:Angioedema / Q000188:drug therapy*; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab / Q000627:therapeutic use*; D013160:Splenic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D001323:Autoantibodies; D000069283:Rituximab; D003165:Complement System Proteins